Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
NCT05537896Phase 2Recruiting
- Sponsor
- West Virginia University
- Start
- Feb 2024
- Primary completion
- Feb 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eravacycline in bacterial infection, sponsored by West Virginia University. Started Feb 2024; status: recruiting.
02
Drugs
eravacycline
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05537896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05537896.